MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pharmacyclics Company Profile (NASDAQ:PCYC)

Consensus Ratings for Pharmacyclics (NASDAQ:PCYC) (?)
Ratings Breakdown: 16 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $209.24 (18.62% downside)

Current Analysts' Coverage Summary for Pharmacyclics (NASDAQ:PCYC)
Show:
DateFirmActionRatingPrice TargetActions
5/29/2015BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015BMO Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Credit SuisseReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015WallachBeth CapitalBoost Price TargetHold$222.00 -> $261.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015Piper JaffraySet Price TargetHold$184.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015NomuraDowngradeBuy -> Neutral$196.00 -> $261.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015Wells Fargo & Co.DowngradeOutperform -> Market Perform$261.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015RBC CapitalBoost Price TargetSector Perform$145.00 -> $261.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015WedbushDowngradeOutperform -> Neutral$225.00 -> $234.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Goldman SachsDowngradeHold$184.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Robert W. BairdBoost Price Target$240.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Deutsche BankDowngradeBuy -> Hold$235.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Stifel NicolausReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$152.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015Roth CapitalDowngradeBuy -> Neutral$189.00 -> $187.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2015Citigroup Inc.Boost Price TargetBuy$145.00 -> $155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014JMP SecuritiesReiterated RatingMarket Outperform$200.00 -> $204.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Morgan StanleyReiterated RatingEqual Weight$103.00 -> $111.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014William BlairBoost Price Target$186.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014SunTrustInitiated CoverageNeutral$140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Lazard Capital MarketsReiterated RatingBuy$141.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/31/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha